Wells Fargo
BIVI icon

Wells Fargo’s BioVie BIVI Stock Holding History

Wells Fargo’s Portfolio BIVI Stock Details BIVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$38 Sell
27
-2
-7% -$3 ﹤0.01% 6648
2025
Q4 		$34 Sell
29
-15
-34% -$24 ﹤0.01% 6610
2025
Q3 		$84 Buy
44
+4
+10% +$16 ﹤0.01% 6406
2025
Q2 		$365 Sell
40
-100
-71% -$988 ﹤0.01% 6405
2025
Q1 		$1.37K Sell
140
-15
-10% -$240 ﹤0.01% 6202
2024
Q4 		$3.09K Buy
155
+100
+182% +$2.41K ﹤0.01% 6132
2024
Q3 		$660 Hold
55
– – ﹤0.01% 6152
2024
Q2 		$2.2K Sell
55
-39
-41% -$1.87K ﹤0.01% 6001
2024
Q1 		$4.96K Buy
94
+8
+9% +$820 ﹤0.01% 5892
2023
Q4 		$10.8K Buy
86
+24
+39% +$7.21K ﹤0.01% 5820
2023
Q3 		$21.1K Sell
62
-7
-10% -$2.74K ﹤0.01% 5574
2023
Q2 		$29.9K Buy
69
+13
+23% +$8.76K ﹤0.01% 5618
2023
Q1 		$45K Sell
56
-14
-20% -$9.28K ﹤0.01% 5215
2022
Q4 		$54.7K Buy
70
+43
+159% +$23.2K ﹤0.01% 4817
2022
Q3 		$7K Hold
27
– – ﹤0.01% 5800
2022
Q2 		$4K Hold
27
– – ﹤0.01% 6068
2022
Q1 		$13K Buy
+27
New +$9.97K ﹤0.01% 6166
2021
Q4 		– Hold
0
– – – 7222
2021
Q3 		– Hold
0
– – – 6971
2021
Q2 		– Hold
0
– – – 6904
2021
Q1 		– Hold
0
– – – 6887
2020
Q4 		– Hold
0
– – – 6488

Other funds holding BIVI

DC
Diametric Capital Boston, Massachusetts $385M AUM 31.69% 1-Year Est. Return
PCM
Prelude Capital Management New York $1.31B AUM 62.01% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PTC
Philadelphia Trust Company Philadelphia, Pennsylvania $1.42B AUM 43.77% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Wells Fargo's BIVI Position: Q1 2026 in Review

Wells Fargo reduced its BioVie (BIVI) stake by 6.9% in Q1 2026, selling an estimated $3 and leaving 27 shares worth $38. The position accounts for ﹤0.01% of the portfolio, ranked #6648.

Wells Fargo first reported a position in BIVI in Q1 2022 and has held it in 17 quarters since. The position peaked at $54.7K in Q4 2022. 33 funds tracked by Wall St. Rank hold BIVI as of Q1 2026.

  • Wells Fargo held 27 shares of BioVie worth $38 as of Q1 2026.
  • Wells Fargo sold 2 BioVie shares in Q1 2026, an estimated $3.
  • BioVie made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #6648 holding.
  • Wells Fargo first reported a position in BioVie in Q1 2022 and has held it in 17 quarters since.
  • Wells Fargo's BioVie position peaked at $54.7K in Q4 2022.
  • 33 funds tracked by Wall St. Rank held BioVie as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.